Registrar, a portfolio company of Bertram Capital since June 2018, has acquired FDA Agents. This is the first add-on acquisition completed by Registrar under Bertram ownership.
FDA Agents services are used to help US and internationally-based businesses comply with US FDA regulations. The company focuses primarily on registration and US Agent services for the food, beverage, medical device, and pharmaceutical sectors and has more than 1,000 customers worldwide. FDA registration is required for all facilities that manufacture, process, pack, or store food, beverages, or dietary supplements that may be consumed in the United States by humans or animals. Companies located outside the United States must designate a US Agent for FDA communications. FDA Agents was founded in 2003 and is headquartered northwest of San Antonio in Tarpley, TX (www.fdaagents.com).
“With ever increasing regulations, it was the right time for FDA Agents to partner with a larger organization that could offer our customers a fuller breadth of solutions,” said John Balistreri, Managing Director of FDA Agents. “Registrar greatly expands the capabilities of FDA Agents and I am confident that our valued clients will benefit from the variety of compliance services Registrar offers and the access to their international offices.”
Similar to FDA Agents, Registrar was founded in 2003 to help businesses comply with US FDA regulations. Registrar offers FDA compliance assistance for the food and beverage, medical device, drugs, cosmetics, electronics, and tobacco industries. Since its founding, the company has provided its services to more than 30,000 companies in 160 countries. In addition to its headquarters in Hampton, VA, the company has seventeen international offices (www.registrarcorp.com).
“Our goal is to expand Registrar’s reach across the FDA-regulated market,” said David Lennarz, Registrar’s President of Business Development and Operations. “We are excited to partner with all of FDA Agents’ customers and support their ongoing regulatory compliance needs by leveraging Registrar’s 100-plus regulatory advisors and specialists, offices in 17 countries, and unique SaaS technology capabilities.”
Bertram and Registrar continue to actively target add-on acquisitions of FDA regulatory compliance firms that can expand Registrar’s client base and range of services. “Registrar offers a specialized suite of FDA compliance solutions beyond what can be found in the market,” said Tom Beerle, Principal at Bertram Capital. “With the acquisition of FDA Agents, Registrar continues to expand its position as a leading provider of FDA compliance solutions, and moving forward we will continue to pursue additional, strategic add-on investment opportunities.”
Bertram invests in middle-market business services, consumer, industrial and manufacturing companies that have revenues from $25 million to $250 million and EBITDA of $5 million to $30 million. The firm is headquartered south of San Francisco in San Mateo, CA (www.bertramcapital.com).
© 2018 Private Equity Professional | October 17, 2018
